HOME >> BIOLOGY >> NEWS
Gene therapy for chicken model of childhood blindness

In this week's PLoS Medicine Susan Semple-Rowland and colleagues, from the University of Florida, report the results of gene therapy for a chicken model of Leber congenital amaurosis (LCA), one of a group of hereditary diseases that cause blindness in infants and children.

Leber congenital amaurosis (LCA) is the name of a group of hereditary diseases that cause blindness in infants and children. Changes in any one of a number of different genes can cause the blindness, which usually comes on quite soon after birth. About 20% of children with LCA have the most common type called LCA1 which is caused by defects in a gene called retinal guanylate cyclase (GUCY2D). Defects in the gene leave the light sensitive photoreceptors in the eye unable to respond to light, and so cause blindness. Loss of function of these receptor cells leads to their degeneration and eventually breakdown of the retina the light sensitive tissue at the back of the eye.

There is an animal model of LCA1, a strain of chickens with a mutation in the chicken GUCY2D gene. These chickens develop a disease very similar to that of humans. Gene therapy works by replacing a defective gene with a normal functional one, usually by packaging the normal gene into a harmless virus and injecting it into the affected area, in this case the eye.

The researchers injected a virus containing the normal gene into chicken embryos that had the abnormal gene, and allowed the chicks to hatch normally. Of seven treated chicks, six appeared to develop sight, in contrast to untreated animals. The improvement in the chicks' sight occurred despite the fact that only a relatively small percentage of the receptor cells were infected by the virus.

This study shows that in theory it is possible to treat this form of childhood blindness by gene therapy. However, before clinical trials can be considered for humans, researchers would need to demonstrate that the virus is safe in humans, and addition
'"/>

Contact: Andrew Hyde
ahyde@plos.org
44-012-234-63330
Public Library of Science
22-May-2006


Page: 1 2

Related biology news :

1. Testosterone replacement therapy: How safe for aging men?
2. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
3. Aggressive therapy best for certain AML patients
4. Under magnetic force, nanoparticles may deliver gene therapy
5. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
6. Stem cell therapy rescues motor neurons in ALS model
7. Study identifies new gene therapy tools for inherited blindness
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
10. Nodal status is best predictor of outcome after neoadjuvant therapy for esophageal cancer
11. Scientists follow familiar TRAIL to new cancer therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/5/2018)... BOSTON (PRWEB) , ... October 04, 2018 , ... ... cloud-based enterprise-class unified communications and collaboration solutions, was present at Microsoft Ignite 2018, ... Office 365 communication solutions. , Microsoft issued a statement about the new direction ...
(Date:10/5/2018)... ... October 04, 2018 , ... Nothing brings a team together ... so popular. , Cooking appeals to companies because it encourages a range ... cohesion, collaboration and decision-making skills. It’s also appealing in that everyone – no ...
(Date:10/2/2018)... ... 2018 , ... Stuart is a fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite ... loves playing ball so much that whenever anyone comes to our door, he grabs a ... fetch.” In early 2017, Stuart began limping and eventually could no longer play fetch. ...
Breaking Biology News(10 mins):
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. ... availability of the GlycoMark test, the only FDA-cleared blood test specific to detecting ... will promote and offer the GlycoMark test to its network of physicians through ...
(Date:9/27/2018)... N.J. (PRWEB) , ... September 26, 2018 , ... ... DNA testing are way ahead of their primary care physicians, according to a ... For this study, patients and doctors were asked about consumer adoption of fitness ...
(Date:9/27/2018)... ... September 27, 2018 , ... This past weekend at ... Mobile Technology, Inc. announced they will formally merge companies and integrate their technologies ... (TB) and other diseases. These two social enterprise corporations, both of which focus ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform with Flagship’s ... to empower clinical trials in the immuno-oncology (IO) space. , IO therapies ...
Breaking Biology Technology:
Cached News: